文献速递消化内镜

新型1L聚乙二醇+抗坏血酸与高容量聚乙二醇方案用于结肠镜肠道准备的多中心随机IV期研究

Novel 1-L polyethylene glycol + ascorbate versus high-volume polyethylene glycol regimen for colonoscopy cleansing: a multicenter, randomized, phase IV study.
PubMed 文献 · Gastrointest Endosc · 2021-04-30

结果显示1L-PEG+ASC在全结肠和右半结肠清洁方面均非劣于4L-PEG,且患者依从性更高,安全性和耐受性无差异。

要点

  • 1L-PEG+ASC组依从性92.7%,高于4L-PEG组的81.1%。
  • 两组腺瘤检出率无差异(38.8% vs 43.0%),中重度不良反应亦无差异。

核心结论

  • 1L-PEG+ASC在肠道清洁方面非劣于4L-PEG,且患者依从性更高,安全性和耐受性无差异。

研究设计与样本

  • 肠道准备由当地内镜医师和中心化阅片独立评估,均对随机分组设盲,主要终点为1L-PEG+ASC肠道清洁的非劣效性。

主要发现

  • 依从性:1L-PEG+ASC组178/192例(92.7%) vs 4L-PEG组154/190例(81.1%)(RR 1.10,95%CI 1.05-1.12)。
  • 腺瘤检出率:1L-PEG+ASC组38.8% vs 4L-PEG组43.0%,无差异。

临床怎么用

  • 对于结肠镜肠道准备,可考虑使用分次1L-PEG+ASC方案,其清洁效果不劣于4L-PEG且依从性更高。
  • 该方案安全性与4L-PEG相当,腺瘤检出率无差异,可作为高容量方案的替代选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Adequate bowel cleansing is critical to ensure quality and safety of a colonoscopy. A novel 1-L polyethylene glycol plus ascorbate (1L-PEG+ASC) regimen was previously validated against low-volume regimens but was never compared with high-volume regimens. METHODS: In a phase IV study, patients undergoing colonoscopy were randomized 1:1 to receive split-dose 1L PEG+ASC or a split-dose 4-L PEG-based regimen (4L-PEG) in 5 Italian centers. Preparation was assessed with the Boston Bowel Preparation Scale (BBPS) by local endoscopists and centralized reading, both blinded to the randomization arm. The primary endpoint was noninferiority of 1L-PEG+ASC in colon cleansing. Secondary endpoints were superiority of 1L-PEG+ASC, patient compliance, segmental colon cleansing, adenoma detection rate, tolerability, and safety. RESULTS: Three hundred eighty-eight patients (median age, 59.8 years) were randomized between January 2019 and October 2019: 195 to 1L-PEG+ASC and 193 to 4L-PEG. Noninferiority of 1L-PEG+ASC was demonstrated for cleansing in both the entire colon (BBPS ≥ 6: 97.9% vs 93%; relative risk [RR], 1.03; 95% confidence interval [CI], 1.001-1.04; P superiority = .027) and in the right-sided colon segment (98.4% vs 96.0%; RR, 1.02; 95% CI, .99-1.02; P noninferiority = .013). Compliance was higher with 1L-PEG+ASC than with 4L-PEG (178/192 [92.7%] vs 154/190 patients [81.1%]; RR, 1.10; 95% CI, 1.05-1.12), whereas no difference was found regarding safety (moderate/severe side effects: 20.8% vs 25.8%; P = .253). No difference in adenoma detection rate (38.8% vs 43.0%) was found. CONCLUSIONS: One-liter PEG+ASC showed noninferiority compared with 4L-PEG in achieving adequate colon cleansing and provided a higher patient compliance. No differences in tolerability and safety were detected. (Clinical trial registration number: NCT03742232.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Repici A, Spada C, Cannizzaro R, et al. Novel 1-L polyethylene glycol + ascorbate versus high-volume polyethylene glycol regimen for colonoscopy cleansing: a multicenter, randomized, phase IV study. Gastrointest Endosc. 2021. PMID: 33940043. doi:10.1016/j.gie.2021.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。